Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Skarka

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Planta Medica|October 21, 2015
Essential Oil from Myrica rubra Leaves Potentiated Antiproliferative and Prooxidative Effect of Doxorubicin and its Accumulation in Intestinal Cancer CellsMartin Ambrož, Veronika Hanušová, Adam Skarka, et al.
Toxicology|July 29, 2009
Partial purification and characterization of a new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracinLucie Skarydová, Adam Skarka, Romana Novotná, et al.
International Journal of Molecular Sciences|September 22, 2019
The Evaluation of Glioblastoma Cell Dissociation and Its Influence on Its BehaviorVeronika Skarkova, Marketa Krupova, Barbora Vitovcova, et al.
Frontiers in Pharmacology|June 14, 2019
Carbonyl Reduction of Flubendazole in the Human Liver: Strict Stereospecificity, Sex Difference, Low Risk of Drug InteractionsVladimír Kubíček, Lenka Skálová, Adam Skarka, et al.
Chemico-Biological Interactions|December 3, 2014
Molecular and biochemical characterisation of human short-chain dehydrogenase/reductase member 3 (DHRS3)Tereza Lundová, Lucie Zemanová, Beata Malčeková, et al.
Molecules (Basel, Switzerland)|August 27, 2015
The Influence of Sesquiterpenes from Myrica rubra on the Antiproliferative and Pro-Oxidative Effects of Doxorubicin and Its Accumulation in Cancer CellsMartin Ambrož, Iva Boušová, Adam Skarka, et al.
Toxicology and Applied Pharmacology|December 13, 2021
Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporterDimitrios Vagiannis, Yu Zhang, Youssif Budagaga, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 15, 2017
The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing miceVeronika Hanušová, Kateřina Caltová, Hana Svobodová, et al.
Cancers|April 2, 2020
Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation EnzymeDimitrios Vagiannis, Eva Novotna, Adam Skarka, et al.
Cancers|October 27, 2022
Role of N-Cadherin in Epithelial-to-Mesenchymal Transition and Chemosensitivity of Colon Carcinoma CellsVeronika Skarkova, Barbora Vitovcova, Petra Matouskova, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Planta Medica|October 21, 2015
Essential Oil from Myrica rubra Leaves Potentiated Antiproliferative and Prooxidative Effect of Doxorubicin and its Accumulation in Intestinal Cancer CellsMartin Ambrož, Veronika Hanušová, Adam Skarka, et al.
Toxicology|July 29, 2009
Partial purification and characterization of a new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracinLucie Skarydová, Adam Skarka, Romana Novotná, et al.
International Journal of Molecular Sciences|September 22, 2019
The Evaluation of Glioblastoma Cell Dissociation and Its Influence on Its BehaviorVeronika Skarkova, Marketa Krupova, Barbora Vitovcova, et al.
Frontiers in Pharmacology|June 14, 2019
Carbonyl Reduction of Flubendazole in the Human Liver: Strict Stereospecificity, Sex Difference, Low Risk of Drug InteractionsVladimír Kubíček, Lenka Skálová, Adam Skarka, et al.
Chemico-Biological Interactions|December 3, 2014
Molecular and biochemical characterisation of human short-chain dehydrogenase/reductase member 3 (DHRS3)Tereza Lundová, Lucie Zemanová, Beata Malčeková, et al.
Molecules (Basel, Switzerland)|August 27, 2015
The Influence of Sesquiterpenes from Myrica rubra on the Antiproliferative and Pro-Oxidative Effects of Doxorubicin and Its Accumulation in Cancer CellsMartin Ambrož, Iva Boušová, Adam Skarka, et al.
Toxicology and Applied Pharmacology|December 13, 2021
Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporterDimitrios Vagiannis, Yu Zhang, Youssif Budagaga, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 15, 2017
The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing miceVeronika Hanušová, Kateřina Caltová, Hana Svobodová, et al.
Cancers|April 2, 2020
Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation EnzymeDimitrios Vagiannis, Eva Novotna, Adam Skarka, et al.
Cancers|October 27, 2022
Role of N-Cadherin in Epithelial-to-Mesenchymal Transition and Chemosensitivity of Colon Carcinoma CellsVeronika Skarkova, Barbora Vitovcova, Petra Matouskova, et al.
Pageof 4